Traditional CAR-T vs In Vivo CAR-T: The Next Evolution in Cancer Immunotherapy
Traditional CAR-T vs In Vivo CAR-T: The Next Evolution in Cancer Immunotherapy Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized cancer treatment by reprogramming a patient’s own immune cells to attack cancer. However, traditional CAR-T treatments come with logistical and clinical limitations that have sparked the development of a new generation: in vivo CAR-T therapies. … 더 읽기